Project Grant R01NS140610
Award Date
1/1/25
Completion Date
12/31/29
Dollars Obligated
$654K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support a study to compare cerebral energy metabolism between patients with post-acute sequelae of SARS-CoV-2 infection (PASC) who have developed myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and patients with non-PASC ME/CFS. The $670,721 award will fund non-invasive brain...
This Project Grant award of $634,622 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to investigate the mechanisms by which SARS-CoV-2 infection leads to neurological post-acute sequelae, known as "NeuroPASC."
The key objectives are to: 1) Acquire high-resolution ex vivo MRI and histological datasets from brain samples of...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $797,157 to Yale University to investigate the underlying neurological changes associated with the neuropsychiatric symptoms of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC or "Long COVID"). The research aims to identify specific brain circuitry and functional changes that contribute to cognitive, mood, and autonomic nervous...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will provide $665,125 to Emory University to leverage induced pluripotent stem cell (iPSC) technology to study the neurological and psychiatric symptoms associated with post-acute sequelae of SARS-CoV-2 infection (PASC), also known as "long COVID."
The key objectives are to: 1) perform...
This federal Project Grant award for $801,329.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to investigate how SARS-CoV-2 infection can lead to long-lasting neurological issues in COVID-19 survivors, known as post-acute sequelae of COVID-19 (NEUROPASC). Specifically, the research will examine how disruption of the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $231,524 to Yale University to investigate magnetic resonance imaging (MRI) biomarkers of post-COVID-19 cerebral microvascular dysfunction. The objective is to understand the role of cerebral microvascular dysfunction in the neurological post-acute sequelae of SARS-CoV-2 infection...
This federal Project Grant award from the Department of Health and Human Services National Institutes of Health Office of the Director provided $14,427,699 to New York University School of Medicine for the period of May 24, 2021 through May 23, 2022. The award was made under the Lung Diseases Research program (CFDA #93.838) to support the POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION INITIATIVE: NYU LANGONE HEALTH CLINICAL SCIENCE CORE, DATA RESOURCE CORE, AND PASC BIOREPOSITORY...
This Project Grant award, with Federal Grant Award ID R56NS138437, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The $1,120,805 grant, awarded on Jul 15, 2024, will support research at the University of Illinois to investigate the impact of prior SARS-CoV-2 infection on the cerebrovascular system and its contribution to the development of vascular...
The National Institute on Aging (NIA) awarded a 3-year, $2,561,480 Project Grant (CFDA 93.866) to Brigham & Women's Hospital to study the post-acute sequelae of SARS-CoV-2 infection (PASC) and subsequent disease progression in individuals with mild cognitive impairment (MCI) or Alzheimer's disease (AD) and related dementias (ADRD). The project aims to: 1) understand the epidemiology of PASC in cognitively impaired individuals; 2) examine the impacts of COVID-19 and PASC on disease...
This federal Project Grant award of $1,000,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research to investigate the neural substrates of fatigue and impaired cognition in individuals with lupus, a condition known as "lupus brain fog." The research will be conducted by The Feinstein Institutes for Medical Research, a non-profit organization and the research arm of Northwell Health, over a 4-year period from...